Results for “”

Entry Author Date Location
Week in Review: Seattle Tech Boom From Amazon to Zestimate 05/26/17 Seattle
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
Amid Budget Concerns, NIH Preps Beta Test for Precision Medicine Plan 05/25/17 National
Smartsheet, Outreach, Echodyne, Bulletproof, and Discuss.io Raise VC 05/24/17 Seattle
Report: Microsoft Buying Cybersecurity Firm Hexadite for $100M 05/24/17 Seattle
With $29M in New Cash, Echodyne Advances “Radar Vision” for Machines 05/22/17 Seattle
Envision the Future: Request Your Invite to Our Napa Summit June 8-9 05/22/17 National
Week in Review: Remembering the Seattle of Chris Cornell and Grunge 05/19/17 Seattle
Bio Roundup: Termeer Tribute, ASCO Peeks, Califf’s New Gigs & More 05/19/17 National
Could Seattle’s Life Science Expertise Support Clean Meat Industry? 05/18/17 Seattle
Check Out The Agenda for What’s Hot in Cancer Immunotherapy 2017 05/18/17 National
Partnership on AI Adds Corporate, NGO Members, Charts Initial Course 05/16/17 Seattle
Week in Review: Microsoft’s Introspective CEO on Trust in Tech 05/12/17 Seattle
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Stalled or Rising Momentum? New York Wrestles With Its Biotech Future 05/10/17 New York
Amazon Devotes New Seattle Headquarters Space to Shelter Homeless 05/10/17 Seattle
Senate Vote Confirms Scott Gottlieb for FDA Commissioner 05/09/17 National
Kite CAR-T Death: An Unwelcome Mystery as FDA Mulls Approval 05/08/17 National
Week in Review: Apple, Microsoft A.I. Investments, ‘Reality Caucus’ 05/05/17 Seattle
VenBio Settles Immunomedics Litigation, SeaGen Nixes Cancer Drug Deal 05/05/17 New York
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
EOW Reading List: A.I. Friends and FWBs; Redefining Human Knowledge 05/04/17 Seattle
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
If Budget Holds, NIH Precision Study Could Be Flush As Volunteers Arrive 05/04/17 National
LevelTen Aims to Satisfy Surging Corporate Renewable Energy Demand 05/03/17 Seattle
Friend & Flowers Return With Wasabi, Take on Amazon in “Hot Storage” 05/03/17 Boston
Analysis: Trump’s First 100 Days Through the Tech Industry Lens 05/02/17 San Francisco
Zymeworks Bags $58M in IPO to Bankroll Cancer Drug Trials 04/28/17 Seattle
After Sarepta’s Surprising FDA Nod, CEO Kaye Plans to Resign 04/28/17 Boston
Bio Roundup: Trumpcare Flails, Spinraza Sales, Batten OK & More 04/28/17 National
Page 1 of 68 next page »